Black Diamond Therapeutics Inc. (BDTX) NASDAQ
$5.01 (0.01) (-0.20%)
Market Cap: $259.62M
As of 04/23/24 04:00 PM EDT. Market closed.
Black Diamond Therapeutics Inc. (BDTX)
NASDAQ
$5.01
(0.01) (-0.20%)
Market Cap: $259.62M
As of 04/23/24 04:00 PM EDT. Market closed.
Add to Portfolio
black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
80
Address
.
PRICE CHART FOR BLACK DIAMOND THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.06
Previous Close
$5.02
Days Range
$4.96 - $5.45
52 week range
$1.43 - $6.85
Volume
356,283
Avg. Volume (30 days)
499,188
Market Cap
$259.62M
Dividend Yield
-
P/E
-
Shares Outstanding
51,717,849
Open
$5.06
Previous Close
$5.02
Days Range
$4.96 - $5.45
52 week range
$1.43 - $6.85
Volume
356,283
Avg. Volume (30 days)
499,188
Market Cap
$259.62M
Dividend Yield
-
P/E
-
Shares Outstanding
51,717,849
FINANCIAL STATEMENTS FOR BLACK DIAMOND THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BLACK DIAMOND THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Behbahani Ali | Director | Mar 15, 2024 | Option Exercise | $4.54 | 3,166 | 14,374 | 51,690 | Apr 03, 2024, 09:00 PM |
| DIXON WENDY L | Director | Mar 15, 2024 | Option Exercise | $4.54 | 3,253 | 14,769 | 38,054 | Apr 03, 2024, 08:49 PM |
| Behbahani Ali | Director | Dec 15, 2023 | Option Exercise | $2.73 | 4,455 | 12,162 | 48,524 | Dec 15, 2023, 04:48 PM |
| DIXON WENDY L | Director | Dec 15, 2023 | Option Exercise | $2.73 | 4,043 | 11,037 | 34,801 | Dec 15, 2023, 04:40 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 17, 2023 | Buy | $2.34 | 400,000 | 934,080 | 8,517,839 | Oct 19, 2023, 03:08 PM |
| Behbahani Ali | Director | Sep 15, 2023 | Option Exercise | $3.60 | 3,299 | 11,876 | 44,069 | Sep 18, 2023, 05:34 PM |
| Velleca Mark A. | PRESIDENT & CEO | Sep 15, 2023 | Option Exercise | $3.60 | 5,208 | 18,749 | 46,522 | Sep 18, 2023, 05:26 PM |
| DIXON WENDY L | Director | Sep 15, 2023 | Option Exercise | $3.60 | 2,986 | 10,750 | 30,758 | Sep 18, 2023, 05:25 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 05, 2023 | Buy | $5.00 | 935,850 | 4,679,250 | 3,213,828 | Jul 07, 2023, 04:30 PM |
| Behbahani Ali | Director | Jul 05, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 4,448,757 | Jul 06, 2023, 04:45 PM |
| BIOTECH GROWTH N V | 10% Owner | Jun 30, 2023 | Buy | $5.00 | 1,000,000 | 5,000,000 | 8,117,839 | Jul 03, 2023, 03:36 PM |
| BIOTECH GROWTH N V | 10% Owner | Jun 27, 2023 | Buy | $5.49 | 1,740,000 | 9,555,036 | 7,117,839 | Jun 29, 2023, 01:37 PM |
| Epstein David M. | SEE REMARKS | Jun 27, 2023 | Sale | $6.70 | 25,000 | 167,500 | 671,423 | Jun 28, 2023, 04:02 PM |
| Behbahani Ali | Director | Jun 16, 2023 | Option Exercise | $2.10 | 5,655 | 11,875 | 40,770 | Jun 16, 2023, 06:42 PM |
| DIXON WENDY L | Director | Jun 16, 2023 | Option Exercise | $2.10 | 5,119 | 10,750 | 27,772 | Jun 16, 2023, 05:41 PM |
| Velleca Mark A. | Director | Jun 16, 2023 | Option Exercise | $2.10 | 8,929 | 18,751 | 41,314 | Jun 16, 2023, 05:41 PM |
| Behbahani Ali | Director | Mar 16, 2023 | Option Exercise | $1.67 | 7,111 | 11,875 | 35,115 | Mar 20, 2023, 04:41 PM |
| DIXON WENDY L | Director | Mar 16, 2023 | Option Exercise | $1.67 | 6,437 | 10,750 | 22,653 | Mar 20, 2023, 04:34 PM |
| Velleca Mark A. | Director | Mar 16, 2023 | Option Exercise | $1.67 | 11,228 | 18,751 | 32,385 | Mar 20, 2023, 04:33 PM |
| Ni Fang | SEE REMARKS | Dec 22, 2022 | Buy | $1.28 | 36,363 | 46,596 | 125,389 | Dec 23, 2022, 04:23 PM |
| Ni Fang | SEE REMARKS | Dec 21, 2022 | Buy | $1.29 | 20,000 | 25,770 | 89,026 | Dec 23, 2022, 04:23 PM |
| Behbahani Ali | Director | Dec 16, 2022 | Option Exercise | $1.50 | 7,917 | 11,876 | 28,004 | Dec 19, 2022, 09:27 PM |
| Velleca Mark A. | Director | Dec 16, 2022 | Option Exercise | $1.50 | 8,424 | 12,636 | 21,157 | Dec 19, 2022, 09:16 PM |
| DIXON WENDY L | Director | Dec 16, 2022 | Option Exercise | $1.50 | 7,167 | 10,751 | 16,216 | Dec 19, 2022, 09:15 PM |
| INGRAM ROBERT ALEXANDER | FORMER DIRECTOR | Dec 16, 2022 | Option Exercise | $1.50 | 9,375 | 14,063 | 42,854 | Dec 19, 2022, 09:14 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 31, 2022 | Buy | $2.25 | 99,801 | 224,912 | 5,377,839 | Nov 02, 2022, 03:10 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 28, 2022 | Buy | $2.18 | 172,974 | 376,962 | 5,278,038 | Oct 31, 2022, 03:20 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 27, 2022 | Buy | $1.87 | 191,678 | 359,224 | 5,105,064 | Oct 31, 2022, 03:20 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 21, 2022 | Buy | $1.51 | 87,850 | 132,750 | 4,913,386 | Oct 25, 2022, 04:24 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 19, 2022 | Buy | $1.32 | 77,689 | 102,775 | 4,771,802 | Oct 21, 2022, 03:06 PM |
| BIOTECH GROWTH N V | 10% Owner | Oct 20, 2022 | Buy | $1.42 | 53,734 | 76,345 | 4,825,536 | Oct 21, 2022, 03:06 PM |
| Behbahani Ali | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,532 | 11,874 | 20,087 | Sep 19, 2022, 06:39 PM |
| DIXON WENDY L | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,103 | 10,750 | 9,049 | Sep 19, 2022, 05:10 PM |
| Velleca Mark A. | Director | Sep 16, 2022 | Option Exercise | $2.62 | 4,294 | 11,250 | 12,733 | Sep 19, 2022, 05:09 PM |
| INGRAM ROBERT ALEXANDER | Director | Sep 16, 2022 | Option Exercise | $2.62 | 6,584 | 17,250 | 33,479 | Sep 19, 2022, 05:08 PM |
| DIXON WENDY L | Director | Jun 17, 2022 | Option Exercise | $2.03 | 4,946 | 10,040 | 4,946 | Jun 30, 2022, 04:07 PM |
| Ni Fang | SEE REMARKS | Jun 29, 2022 | Buy | $2.44 | 25,000 | 61,018 | 69,026 | Jun 30, 2022, 04:05 PM |
| Behbahani Ali | Director | Jun 17, 2022 | Option Exercise | $2.03 | 5,850 | 11,875 | 15,555 | Jun 17, 2022, 04:35 PM |
| Velleca Mark A. | Director | Jun 17, 2022 | Option Exercise | $2.03 | 5,542 | 11,250 | 8,439 | Jun 17, 2022, 04:27 PM |
| DIXON WENDY L | Director | Jun 17, 2022 | Option Exercise | $2.03 | 4,060 | 8,242 | 4,060 | Jun 17, 2022, 04:26 PM |
| INGRAM ROBERT ALEXANDER | Director | Jun 17, 2022 | Option Exercise | $2.03 | 8,498 | 17,251 | 26,895 | Jun 17, 2022, 04:25 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 28, 2022 | Buy | $2.57 | 255,711 | 657,868 | 4,694,113 | Apr 29, 2022, 10:50 AM |
| BIOTECH GROWTH N V | 10% Owner | Apr 27, 2022 | Buy | $2.66 | 150,000 | 399,480 | 4,438,402 | Apr 29, 2022, 10:50 AM |
| BIOTECH GROWTH N V | 10% Owner | Apr 19, 2022 | Buy | $3.24 | 150,000 | 486,645 | 4,288,402 | Apr 20, 2022, 12:56 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 18, 2022 | Buy | $3.29 | 150,000 | 493,935 | 4,138,402 | Apr 20, 2022, 12:56 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 13, 2022 | Buy | $3.57 | 102,556 | 366,217 | 3,988,402 | Apr 14, 2022, 12:09 PM |
| BIOTECH GROWTH N V | 10% Owner | Apr 12, 2022 | Buy | $3.42 | 150,000 | 513,600 | 3,885,846 | Apr 14, 2022, 12:09 PM |
| Behbahani Ali | Director | Mar 18, 2022 | Option Exercise | $3.02 | 4,346 | 13,125 | 9,705 | Mar 18, 2022, 04:15 PM |
| INGRAM ROBERT ALEXANDER | Director | Mar 18, 2022 | Option Exercise | $3.02 | 5,795 | 17,501 | 18,397 | Mar 18, 2022, 04:05 PM |
| Velleca Mark A. | Director | Mar 18, 2022 | Option Exercise | $3.02 | 2,897 | 8,749 | 2,897 | Mar 18, 2022, 04:05 PM |
| Behbahani Ali | Director | Dec 17, 2021 | Option Exercise | $5.31 | 2,472 | 13,126 | 5,359 | Dec 17, 2021, 04:50 PM |
| INGRAM ROBERT ALEXANDER | Director | Dec 17, 2021 | Option Exercise | $5.31 | 3,296 | 17,502 | 12,602 | Dec 17, 2021, 04:12 PM |
| Behbahani Ali | Director | Sep 17, 2021 | Option Exercise | $9.90 | 1,326 | 13,127 | 2,887 | Sep 23, 2021, 05:43 PM |
| INGRAM ROBERT ALEXANDER | Director | Sep 17, 2021 | Option Exercise | $9.90 | 1,869 | 18,503 | 9,306 | Sep 23, 2021, 05:33 PM |
| INGRAM ROBERT ALEXANDER | Director | Jun 18, 2021 | Option Exercise | $12.95 | 1,255 | 16,252 | 7,437 | Jun 22, 2021, 06:13 PM |
| Hatzis-Schoch Brent | See Remarks | May 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | May 13, 2021, 04:53 PM |
| Hatzis-Schoch Brent | See Remarks | May 12, 2021 | Sale | $27.42 | 4,078 | 111,805 | 11,317 | May 13, 2021, 04:53 PM |
| Roberts Christopher D. | Chief Scientific Officer | May 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | May 05, 2021, 04:31 PM |
| Roberts Christopher D. | Chief Scientific Officer | May 03, 2021 | Sale | $26.64 | 2,500 | 66,602 | 3,200 | May 05, 2021, 04:31 PM |
| Hatzis-Schoch Brent | See Remarks | Apr 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Apr 13, 2021, 08:45 PM |
| Hatzis-Schoch Brent | See Remarks | Apr 12, 2021 | Sale | $25.00 | 4,078 | 101,950 | 8,400 | Apr 13, 2021, 08:45 PM |
| Shah Rajeev M. | Director | Apr 01, 2021 | Option Exercise | $24.26 | 353,814 | 8,583,528 | 2,277,978 | Apr 05, 2021, 04:34 PM |
| Behbahani Ali | Director | Mar 18, 2021 | Option Exercise | $24.01 | 547 | 13,133 | 547 | Mar 22, 2021, 08:33 PM |
| Shah Rajeev M. | Director | Mar 18, 2021 | Option Exercise | $24.01 | 443 | 10,636 | 443 | Mar 22, 2021, 08:25 PM |
| INGRAM ROBERT ALEXANDER | Director | Mar 18, 2021 | Option Exercise | $24.01 | 677 | 16,255 | 6,182 | Mar 22, 2021, 08:19 PM |
| Hatzis-Schoch Brent | See Remarks | Mar 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Mar 16, 2021, 04:56 PM |
| Hatzis-Schoch Brent | See Remarks | Mar 12, 2021 | Sale | $26.36 | 4,078 | 107,493 | 8,400 | Mar 16, 2021, 04:56 PM |
| Roberts Christopher D. | Chief Scientific Officer | Mar 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Mar 04, 2021, 05:52 PM |
| Roberts Christopher D. | Chief Scientific Officer | Mar 03, 2021 | Sale | $26.10 | 2,500 | 65,262 | 4,084 | Mar 04, 2021, 05:52 PM |
| Hatzis-Schoch Brent | See Remarks | Feb 12, 2021 | Option Exercise | $3.20 | 4,078 | 13,050 | 12,478 | Feb 12, 2021, 09:24 PM |
| Hatzis-Schoch Brent | See Remarks | Feb 12, 2021 | Sale | $27.23 | 4,078 | 111,025 | 8,707 | Feb 12, 2021, 09:24 PM |
| Roberts Christopher D. | Chief Scientific Officer | Feb 03, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Feb 04, 2021, 05:47 PM |
| Roberts Christopher D. | Chief Scientific Officer | Feb 03, 2021 | Sale | $25.35 | 2,500 | 63,375 | 3,200 | Feb 04, 2021, 05:47 PM |
| Hatzis-Schoch Brent | See Remarks | Jan 12, 2021 | Option Exercise | $8.16 | 11,578 | 94,500 | 19,978 | Jan 14, 2021, 08:57 PM |
| Hatzis-Schoch Brent | See Remarks | Jan 12, 2021 | Sale | $34.03 | 11,578 | 394,041 | 17,930 | Jan 14, 2021, 08:57 PM |
| Leggett Thomas | Chief Financial Officer | Jan 08, 2021 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Jan 11, 2021, 05:59 PM |
| Leggett Thomas | Chief Financial Officer | Jan 08, 2021 | Sale | $33.94 | 3,000 | 101,820 | 0 | Jan 11, 2021, 05:59 PM |
| Roberts Christopher D. | Chief Scientific Officer | Jan 04, 2021 | Option Exercise | $10.86 | 2,500 | 27,150 | 5,700 | Jan 06, 2021, 06:27 PM |
| Roberts Christopher D. | Chief Scientific Officer | Jan 04, 2021 | Sale | $31.41 | 2,500 | 78,525 | 3,737 | Jan 06, 2021, 06:27 PM |
| Epstein David M. | See Remarks | Jan 04, 2021 | Option Exercise | $6.42 | 3,000 | 19,260 | 708,423 | Jan 06, 2021, 06:21 PM |
| Epstein David M. | See Remarks | Jan 04, 2021 | Sale | $31.13 | 12,000 | 373,505 | 698,438 | Jan 06, 2021, 06:21 PM |
| Hatzis-Schoch Brent | See Remarks | Dec 28, 2020 | Option Exercise | $3.20 | 5,400 | 17,280 | 8,400 | Dec 29, 2020, 04:46 PM |
| INGRAM ROBERT ALEXANDER | Director | Dec 15, 2020 | Option Exercise | $34.29 | 505 | 17,316 | 5,505 | Dec 16, 2020, 07:42 PM |
| Roberts Christopher D. | Chief Scientific Officer | Dec 15, 2020 | Option Exercise | $10.86 | 3,200 | 34,752 | 3,200 | Dec 16, 2020, 07:42 PM |
| Hatzis-Schoch Brent | See Remarks | Dec 14, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Dec 16, 2020, 07:41 PM |
| Hatzis-Schoch Brent | See Remarks | Dec 14, 2020 | Sale | $34.95 | 4,078 | 142,522 | 3,000 | Dec 16, 2020, 07:41 PM |
| Epstein David M. | See Remarks | Dec 15, 2020 | Option Exercise | $6.42 | 2,500 | 16,050 | 705,423 | Dec 16, 2020, 07:39 PM |
| Leggett Thomas | Chief Financial Officer | Dec 08, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Dec 10, 2020, 04:16 PM |
| Leggett Thomas | Chief Financial Officer | Dec 08, 2020 | Sale | $33.78 | 3,000 | 101,327 | 1,941 | Dec 10, 2020, 04:16 PM |
| Roberts Christopher D. | Chief Scientific Officer | Dec 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Dec 04, 2020, 04:34 PM |
| Roberts Christopher D. | Chief Scientific Officer | Dec 03, 2020 | Sale | $32.42 | 2,500 | 81,055 | 0 | Dec 04, 2020, 04:34 PM |
| Epstein David M. | See Remarks | Dec 01, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 714,923 | Dec 03, 2020, 04:17 PM |
| Epstein David M. | See Remarks | Dec 01, 2020 | Sale | $32.71 | 12,000 | 392,574 | 704,000 | Dec 03, 2020, 04:17 PM |
| Bolzon Bradley J PhD | Director | Nov 30, 2020 | Sale | $33.15 | 10,393 | 344,513 | 874,299 | Dec 01, 2020, 07:13 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 30, 2020 | Sale | $33.15 | 10,393 | 344,513 | 874,299 | Dec 01, 2020, 07:13 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 114,854 | 3,791,330 | 4,818,600 | Nov 23, 2020, 04:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 19, 2020 | Sale | $33.01 | 15,163 | 500,531 | 968,954 | Nov 23, 2020, 04:41 PM |
| Bolzon Bradley J PhD | Director | Nov 19, 2020 | Sale | $33.01 | 130,017 | 4,291,861 | 4,818,600 | Nov 23, 2020, 04:39 PM |
| Bolzon Bradley J PhD | Director | Nov 18, 2020 | Sale | $33.09 | 536 | 17,738 | 4,933,454 | Nov 19, 2020, 09:19 PM |
| Bolzon Bradley J PhD | Director | Nov 17, 2020 | Sale | $33.05 | 4,194 | 138,611 | 4,933,927 | Nov 19, 2020, 09:19 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 63 | 2,085 | 984,117 | Nov 19, 2020, 09:19 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 3,705 | 122,450 | 4,933,927 | Nov 19, 2020, 09:19 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 17, 2020 | Sale | $33.05 | 489 | 16,161 | 984,180 | Nov 19, 2020, 09:19 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 18, 2020 | Sale | $33.09 | 473 | 15,653 | 4,933,454 | Nov 19, 2020, 09:19 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 177 | 5,843 | 4,937,632 | Nov 17, 2020, 07:33 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 16, 2020 | Sale | $33.01 | 23 | 759 | 984,669 | Nov 17, 2020, 07:33 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 3,975 | 134,253 | 4,939,311 | Nov 17, 2020, 07:33 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 13, 2020 | Sale | $33.77 | 525 | 17,731 | 984,890 | Nov 17, 2020, 07:33 PM |
| Bolzon Bradley J PhD | Director | Nov 16, 2020 | Sale | $33.01 | 200 | 6,603 | 4,937,632 | Nov 17, 2020, 07:28 PM |
| Bolzon Bradley J PhD | Director | Nov 13, 2020 | Sale | $33.77 | 4,500 | 151,984 | 4,939,311 | Nov 17, 2020, 07:28 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 13,779 | 470,526 | 4,951,587 | Nov 13, 2020, 07:47 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 12, 2020 | Sale | $34.15 | 1,819 | 62,116 | 986,512 | Nov 13, 2020, 07:47 PM |
| Bolzon Bradley J PhD | Director | Nov 12, 2020 | Sale | $34.15 | 15,598 | 532,642 | 4,951,587 | Nov 13, 2020, 07:46 PM |
| Roberts Christopher D. | Chief Scientific Officer | Nov 11, 2020 | Option Exercise | $10.86 | 5,000 | 54,300 | 5,000 | Nov 13, 2020, 04:26 PM |
| Roberts Christopher D. | Chief Scientific Officer | Nov 11, 2020 | Sale | $34.90 | 5,000 | 174,500 | 0 | Nov 13, 2020, 04:26 PM |
| Hatzis-Schoch Brent | See Remarks | Nov 12, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Nov 13, 2020, 04:25 PM |
| Hatzis-Schoch Brent | See Remarks | Nov 12, 2020 | Sale | $33.99 | 4,078 | 138,607 | 5,511 | Nov 13, 2020, 04:25 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 23,821 | 805,755 | 5,669,956 | Nov 12, 2020, 05:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 10, 2020 | Sale | $33.83 | 3,145 | 106,381 | 990,149 | Nov 12, 2020, 05:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 11,146 | 387,127 | 5,655,404 | Nov 12, 2020, 05:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 11, 2020 | Sale | $34.73 | 1,471 | 51,091 | 988,227 | Nov 12, 2020, 05:41 PM |
| Bolzon Bradley J PhD | Director | Nov 11, 2020 | Sale | $34.73 | 12,617 | 438,217 | 5,655,404 | Nov 12, 2020, 05:38 PM |
| Bolzon Bradley J PhD | Director | Nov 10, 2020 | Sale | $33.83 | 26,966 | 912,136 | 5,669,956 | Nov 12, 2020, 05:38 PM |
| Leggett Thomas | Chief Financial Officer | Nov 09, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Nov 12, 2020, 05:00 PM |
| Leggett Thomas | Chief Financial Officer | Nov 09, 2020 | Sale | $32.96 | 3,000 | 98,892 | 0 | Nov 12, 2020, 05:00 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 5,565 | 183,954 | 5,681,344 | Nov 10, 2020, 07:24 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 09, 2020 | Sale | $33.06 | 735 | 24,296 | 991,652 | Nov 10, 2020, 07:24 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 2,738 | 90,706 | 5,686,909 | Nov 10, 2020, 07:24 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 06, 2020 | Sale | $33.13 | 362 | 11,993 | 992,387 | Nov 10, 2020, 07:24 PM |
| Bolzon Bradley J PhD | Director | Nov 09, 2020 | Sale | $33.06 | 6,300 | 208,250 | 5,681,344 | Nov 10, 2020, 07:24 PM |
| Bolzon Bradley J PhD | Director | Nov 06, 2020 | Sale | $33.13 | 3,100 | 102,698 | 5,686,909 | Nov 10, 2020, 07:24 PM |
| Bolzon Bradley J PhD | Director | Nov 05, 2020 | Sale | $33.15 | 8,848 | 293,287 | 5,689,647 | Nov 06, 2020, 04:49 PM |
| Bolzon Bradley J PhD | Director | Nov 04, 2020 | Sale | $33.14 | 2,500 | 82,839 | 5,697,463 | Nov 06, 2020, 04:49 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 7,816 | 259,079 | 5,689,647 | Nov 06, 2020, 04:44 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 05, 2020 | Sale | $33.15 | 1,032 | 34,208 | 992,749 | Nov 06, 2020, 04:44 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 2,208 | 73,164 | 5,697,463 | Nov 06, 2020, 04:44 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Nov 04, 2020 | Sale | $33.14 | 292 | 9,676 | 993,781 | Nov 06, 2020, 04:44 PM |
| Roberts Christopher D. | Chief Scientific Officer | Nov 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Nov 04, 2020, 08:37 PM |
| Roberts Christopher D. | Chief Scientific Officer | Nov 03, 2020 | Sale | $31.95 | 2,500 | 79,873 | 0 | Nov 04, 2020, 08:37 PM |
| Epstein David M. | See Remarks | Nov 02, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 723,923 | Nov 03, 2020, 07:56 PM |
| Epstein David M. | See Remarks | Nov 02, 2020 | Sale | $31.14 | 12,000 | 373,656 | 712,006 | Nov 03, 2020, 07:56 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 707 | 23,354 | 5,699,671 | Oct 28, 2020, 05:58 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 27, 2020 | Sale | $33.03 | 93 | 3,072 | 994,073 | Oct 28, 2020, 05:58 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 7,158 | 238,394 | 5,700,378 | Oct 28, 2020, 05:58 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 26, 2020 | Sale | $33.30 | 945 | 31,473 | 994,166 | Oct 28, 2020, 05:58 PM |
| Bolzon Bradley J PhD | Director | Oct 27, 2020 | Sale | $33.03 | 800 | 26,426 | 5,699,671 | Oct 28, 2020, 05:51 PM |
| Bolzon Bradley J PhD | Director | Oct 26, 2020 | Sale | $33.30 | 8,103 | 269,867 | 5,700,378 | Oct 28, 2020, 05:51 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 3,739 | 124,998 | 5,707,536 | Oct 20, 2020, 08:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 19, 2020 | Sale | $33.43 | 494 | 16,515 | 995,111 | Oct 20, 2020, 08:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 7,697 | 258,410 | 5,711,275 | Oct 20, 2020, 08:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 16, 2020 | Sale | $33.57 | 1,016 | 34,110 | 995,605 | Oct 20, 2020, 08:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 2,473 | 81,694 | 5,718,972 | Oct 20, 2020, 08:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 15, 2020 | Sale | $33.03 | 327 | 10,802 | 996,621 | Oct 20, 2020, 08:09 PM |
| Bolzon Bradley J PhD | Director | Oct 19, 2020 | Sale | $33.43 | 4,233 | 141,513 | 5,707,536 | Oct 20, 2020, 08:03 PM |
| Bolzon Bradley J PhD | Director | Oct 16, 2020 | Sale | $33.57 | 8,713 | 292,520 | 5,711,275 | Oct 20, 2020, 08:03 PM |
| Bolzon Bradley J PhD | Director | Oct 15, 2020 | Sale | $33.03 | 2,800 | 92,496 | 5,718,972 | Oct 20, 2020, 08:03 PM |
| Bolzon Bradley J PhD | Director | Oct 14, 2020 | Sale | $33.09 | 5,501 | 182,031 | 5,721,445 | Oct 15, 2020, 07:26 PM |
| Bolzon Bradley J PhD | Director | Oct 13, 2020 | Sale | $33.39 | 11,739 | 391,984 | 5,726,304 | Oct 15, 2020, 07:26 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 10,370 | 346,271 | 5,726,304 | Oct 15, 2020, 07:22 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 13, 2020 | Sale | $33.39 | 1,369 | 45,713 | 997,590 | Oct 15, 2020, 07:22 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 4,859 | 160,787 | 5,721,445 | Oct 15, 2020, 07:22 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 14, 2020 | Sale | $33.09 | 642 | 21,244 | 996,948 | Oct 15, 2020, 07:22 PM |
| Hatzis-Schoch Brent | See Remarks | Oct 12, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Oct 14, 2020, 04:32 PM |
| Hatzis-Schoch Brent | See Remarks | Oct 12, 2020 | Sale | $32.70 | 4,078 | 133,331 | 3,295 | Oct 14, 2020, 04:32 PM |
| Bolzon Bradley J PhD | Director | Oct 08, 2020 | Sale | $33.47 | 18,425 | 616,748 | 5,748,886 | Oct 13, 2020, 07:48 PM |
| Bolzon Bradley J PhD | Director | Oct 12, 2020 | Sale | $33.11 | 400 | 13,243 | 5,736,674 | Oct 13, 2020, 07:48 PM |
| Bolzon Bradley J PhD | Director | Oct 09, 2020 | Sale | $33.67 | 3,800 | 127,933 | 5,737,027 | Oct 13, 2020, 07:48 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 353 | 11,687 | 5,736,674 | Oct 13, 2020, 07:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 12, 2020 | Sale | $33.11 | 47 | 1,556 | 998,959 | Oct 13, 2020, 07:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 3,357 | 113,018 | 5,737,027 | Oct 13, 2020, 07:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 09, 2020 | Sale | $33.67 | 443 | 14,914 | 999,006 | Oct 13, 2020, 07:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 16,276 | 544,814 | 5,748,886 | Oct 13, 2020, 07:41 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 08, 2020 | Sale | $33.47 | 2,149 | 71,934 | 1,000,571 | Oct 13, 2020, 07:41 PM |
| Leggett Thomas | Chief Financial Officer | Oct 08, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Oct 09, 2020, 04:12 PM |
| Leggett Thomas | Chief Financial Officer | Oct 08, 2020 | Sale | $33.53 | 3,000 | 100,576 | 0 | Oct 09, 2020, 04:12 PM |
| Bolzon Bradley J PhD | Director | Oct 07, 2020 | Sale | $33.56 | 27,836 | 934,079 | 5,756,660 | Oct 08, 2020, 07:14 PM |
| Bolzon Bradley J PhD | Director | Oct 06, 2020 | Sale | $33.26 | 18,090 | 601,653 | 5,781,250 | Oct 08, 2020, 07:14 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 15,980 | 531,477 | 5,781,250 | Oct 08, 2020, 07:14 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 06, 2020 | Sale | $33.26 | 2,110 | 70,176 | 1,044,452 | Oct 08, 2020, 07:14 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 24,590 | 825,154 | 5,756,660 | Oct 08, 2020, 07:14 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Oct 07, 2020 | Sale | $33.56 | 3,246 | 108,924 | 1,041,206 | Oct 08, 2020, 07:14 PM |
| Roberts Christopher D. | Chief Scientific Officer | Oct 05, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Oct 07, 2020, 04:27 PM |
| Roberts Christopher D. | Chief Scientific Officer | Oct 05, 2020 | Sale | $31.28 | 2,500 | 78,188 | 227 | Oct 07, 2020, 04:27 PM |
| Epstein David M. | See Remarks | Oct 01, 2020 | Option Exercise | $6.42 | 3,000 | 19,260 | 732,923 | Oct 02, 2020, 05:07 PM |
| Epstein David M. | See Remarks | Oct 01, 2020 | Sale | $30.33 | 12,000 | 363,962 | 720,923 | Oct 02, 2020, 05:07 PM |
| INGRAM ROBERT ALEXANDER | Director | Sep 30, 2020 | Buy | $30.46 | 5,000 | 152,285 | 5,000 | Oct 01, 2020, 04:06 PM |
| Hatzis-Schoch Brent | See Remarks | Sep 14, 2020 | Option Exercise | $3.20 | 4,078 | 13,050 | 7,078 | Sep 16, 2020, 06:11 PM |
| Hatzis-Schoch Brent | See Remarks | Sep 14, 2020 | Sale | $31.04 | 4,078 | 126,583 | 4,393 | Sep 16, 2020, 06:11 PM |
| Leggett Thomas | Chief Financial Officer | Sep 14, 2020 | Option Exercise | $10.86 | 3,000 | 32,580 | 3,000 | Sep 16, 2020, 06:09 PM |
| Leggett Thomas | Chief Financial Officer | Sep 14, 2020 | Sale | $31.00 | 3,000 | 93,000 | 0 | Sep 16, 2020, 06:09 PM |
| Roberts Christopher D. | Chief Scientific Officer | Sep 03, 2020 | Option Exercise | $10.86 | 2,500 | 27,150 | 2,500 | Sep 04, 2020, 05:27 PM |
| Roberts Christopher D. | Chief Scientific Officer | Sep 03, 2020 | Sale | $29.59 | 2,500 | 73,987 | 2,358 | Sep 04, 2020, 05:27 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 6,692 | 221,380 | 6,797,230 | Aug 12, 2020, 07:57 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Aug 11, 2020 | Sale | $33.08 | 883 | 29,211 | 1,125,778 | Aug 12, 2020, 07:57 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 5,492 | 181,446 | 6,803,922 | Aug 12, 2020, 07:57 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Aug 10, 2020 | Sale | $33.04 | 725 | 23,953 | 1,126,661 | Aug 12, 2020, 07:57 PM |
| Bolzon Bradley J PhD | Director | Aug 11, 2020 | Sale | $33.08 | 7,575 | 250,591 | 6,797,230 | Aug 12, 2020, 07:46 PM |
| Bolzon Bradley J PhD | Director | Aug 10, 2020 | Sale | $33.04 | 6,217 | 205,398 | 6,803,922 | Aug 12, 2020, 07:46 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 396,082 | 7,525,558 | 6,809,414 | Feb 05, 2020, 06:02 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 498,654 | 9,474,426 | 2,209,592 | Feb 05, 2020, 06:02 PM |
| Bolzon Bradley J PhD | Director | Feb 03, 2020 | Buy | $19.00 | 894,736 | 16,999,984 | 6,809,414 | Feb 05, 2020, 05:59 PM |
| Shah Rajeev M. | Director | Feb 03, 2020 | Buy | $19.00 | 1,000,000 | 19,000,000 | 1,924,164 | Feb 05, 2020, 05:58 PM |
| Hatzis-Schoch Brent | See Remarks | Feb 03, 2020 | Buy | $19.00 | 3,000 | 57,000 | 3,000 | Feb 05, 2020, 05:55 PM |
| Behbahani Ali | Director | Feb 03, 2020 | Buy | $19.00 | 800,000 | 15,200,000 | 3,448,757 | Feb 05, 2020, 05:55 PM |
| Flynn James E | 10% Owner | Feb 03, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 778,790 | Feb 03, 2020, 01:25 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN BLACK DIAMOND THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 3,525,754 | 0.15% | No change | Other |
| BLACKROCK INC. | 1,350,047 | 0.0001% | -3.58% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 696,969 | 0.02% | No change | Growth |
| CANDRIAM S.C.A. | 540,009 | 0.01% | 8% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 450,400 | 0.00196% | 36.94% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 350,446 | 0.0001% | 8.07% | Other |
CHANGE IN SHARES OUTSTANDING FOR BLACK DIAMOND THERAPEUTICS INC
STOCK BUYBACKS FOR BLACK DIAMOND THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.52%
1Q
12/31/2022
42.12%
4Q
09/30/2022
42.29%
5Q
06/30/2022
42.49%
6Q
03/31/2022
42.58%
7Q
12/31/2021
42.74%
8Q
09/30/2021
42.79%
9Q
06/30/2021
42.93%
10Q
03/31/2021
43.17%
11Q
12/31/2020
43.47%
12Q
09/30/2020
43.95%
13Q
06/30/2020
44.01%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BLACK DIAMOND THERAPEUTICS INC
LOADING...